Public COA audit

GLP3-R · GLP-1 receptor agonist

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
85%
Panels
3/7
Purity (printed)
99.94%

Scored moderately because the document is mostly consistent but carries soft concerns, limited panel coverage (3/7), 3 soft concerns, and notable note: "High purity confirmed". To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CRRT-15-0126-01
Identity method
LCMS/MS (HPLC with UV Detection Coupled with Mass Spectrometry)
Sample date
2026-01-08
Issue date
2026-01-11

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    GLP RT confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.94% average (Vial 1: 99.98%, Vial 2: 99.94%, Vial 3: 99.91%)

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    ≤ 0.05 EU/mL (both replicates)

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    Average purity 99.94% across three vials (99.98%, 99.94%, 99.91%) is excellent and typical for research-grade peptides. HPLC chromatogram shows single dominant peak consistent with stated purity.

  • Mass spec confirmation present

    Mass spectrometry data shows [M+3H]3+ and [M+4H]4+ ions consistent with GLP-1 receptor agonist peptide identity verification.

  • Endotoxin testing performed

    Endotoxin testing completed with two replicates, both passing at ≤ 0.05 EU/mL threshold, appropriate for research peptides.

  • Lab verification limited

    Freedom Diagnostics website (FreedomDiagnosticsTesting.com) and verification system cannot be independently confirmed. Lab claims USA operation but provides minimal accreditation details.

  • Batch documentation complete

    Lot number CRRT-15-0126-01 clearly stated with accession number 2601080270 and search code for verification.

  • Timeline reasonable

    Received 2026-01-08, reported 2026-01-11 (3-day turnaround) is plausible for HPLC/MS and endotoxin testing.

  • Limited testing scope

    COA only includes purity, identity, and endotoxin panels. Missing heavy metals, microbial, sterility, and residual solvent/water testing. This is common for basic research peptide COAs but limits comprehensive quality assurance.

  • Product photos included

    COA includes photos of labeled vials with 'CRUSH' branding. While this adds traceability, it's unusual for third-party lab reports and suggests possible vendor-lab relationship or in-house testing.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.